Home › Research › Tau biomarkers
Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea
Park SA, Chae WS, Kim HJ, Shin HS, Kim S, Im JY, Ahn SI, Min KD et al.. Alzheimer disease and associated disorders, 2017-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Laboratory-specific reference values for cerebrospinal fluid (CSF) Alzheimer disease (AD) biomarkers are necessary. Our objective was to apply well-known CSF biomarkers and redetermine their diagnostic cutoff values for AD in South Korea. CSF samples from matched control subjects (n=71), patients with AD dementia (ADD, n=76), and other neurological disorders with cognitive decline (OND, n=47) were obtained from 6 Korean dementia clinics according to a standardized protocol.
What this study adds
Evidence grade: Low
The record lists 71 participants. This study measured CSF Alzheimer's biomarkers in Korean patients and recalculated diagnostic cutoff values for that population. It addresses how to diagnose Alzheimer's accurately in a specific group, not how to treat or prevent it.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Park, S. A., Chae, W. S., Kim, H. J., Shin, H. S., Kim, S., Im, J. Y., et al. (2017). Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea. Alzheimer disease and associated disorders. https://doi.org/10.1097/wad.0000000000000184
Vancouver
Park SA, Chae WS, Kim HJ, Shin HS, Kim S, Im JY, et al. Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea. Alzheimer disease and associated disorders. 2017. doi:10.1097/wad.0000000000000184. PMID: 28030437.
BibTeX
@article{park2017-28030437,
author = {Park, S. A. and Chae, W. S. and Kim, H. J. and Shin, H. S. and Kim, S. and Im, J. Y. and Ahn, S. I. and Min, K. D. and others},
title = {{Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea}},
journal = {Alzheimer disease and associated disorders},
year = {2017},
doi = {10.1097/wad.0000000000000184},
pmid = {28030437},
url = {https://doi.org/10.1097/wad.0000000000000184}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Our objective was to apply well-known CSF biomarkers and redetermine their diagnostic cutoff values for AD in South Korea.
- CSF samples from matched control subjects (n=71), patients with AD dementia (ADD, n=76), and other neurological disorders with cognitive decline (OND, n=47) were obtained from 6 Korean dementia clinics according to a standardized protocol.
- CSF biomarker concentrations were measured using enzyme-linked immunosorbent assay.
- CSF biomarkers differed significantly between the ADD and control groups (P<0.001 for all), and between the ADD and OND groups (P<0.001 for all).
Why it matters
This study measured CSF Alzheimer's biomarkers in Korean patients and recalculated diagnostic cutoff values for that population. It addresses how to diagnose Alzheimer's accurately in a specific group, not how to treat or prevent it.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants71
- Evidence strengthLow
How this study scored 44/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer disease and associated disorders) |
| Journal's citation record | 1 / 4 | Alzheimer Disease & Associated Disorders: journal h-index 131 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 1 / 4 | 71 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 28 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.5 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 2 / 6 | Cited 3.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Duk Lyul Na: h-index 67 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Sungkyunkwan University: institution h-index 788 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28030437) |
| Free to read | 2 / 2 | Free to read |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1097/wad.0000000000000184
- PubMed: 28030437
- Original source →
- Free full text: Alzheimer Disease & Associated Disorders →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.